Cipla

Molnupiravir: Merck Greenlights Generic Manufacturing of Its COVID Pill

Cipla Gets DCGI Nod to Import Moderna’s Vaccine for India: Sources

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines

Generic Version of Remdesivir to Be Launched in India at Rs 4,800 per 100 mg Vial

COVID-19: Can We Push Pharma Innovation Without Giving Away Pricey Patents?

A Year Since Stock-Outs, India Continues Slow Roll-Out of Child-Friendly HIV Drugs

Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India